Better Guidance from Gannett (GCI) Gives Boost To Newspaper Stocks (NYT, JRN, LEE)
Get Alerts GCI Hot Sheet
Price: $2.57 -4.46%
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 5.9%
EPS Growth %: -571.4%
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 5.9%
EPS Growth %: -571.4%
Join SI Premium – FREE
A number of beaten-down newspaper stocks are seeing interest today on better-than-expected guidance from Gannett Co (NYSE: GCI). Those stocks include The New York Times Company (NYSE: NYT) +10%, Journal Communications Inc. (NYSE: JRN) +10%, McClatchy Company (NYSE: MNI) +12% and Lee Enterprises Inc. (NYSE: LEE) +30%. Gannett is 15% higher.
This morning, Gannett said it sees Q3 EPS of between $0.39 and $0.42, which compares favorably to the consensus of $0.28. Gannett noted, "Although overall advertising revenue comparisons remain difficult, our third quarter year-over-year publishing comparisons improved again versus first and second quarter comparisons."
In addition the company said, "Our continued efforts to achieve efficiencies and further consolidations company-wide along with significantly lower newsprint expense resulted in another substantial decline in our operating expenses. As a result, we continue to generate substantial operating cash flow which enabled us to lower debt by about $195 million in the quarter."
This morning, Gannett said it sees Q3 EPS of between $0.39 and $0.42, which compares favorably to the consensus of $0.28. Gannett noted, "Although overall advertising revenue comparisons remain difficult, our third quarter year-over-year publishing comparisons improved again versus first and second quarter comparisons."
In addition the company said, "Our continued efforts to achieve efficiencies and further consolidations company-wide along with significantly lower newsprint expense resulted in another substantial decline in our operating expenses. As a result, we continue to generate substantial operating cash flow which enabled us to lower debt by about $195 million in the quarter."
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- INmune Bio (INMB) Prices 986K Share Offering at $9.84/sh
- Nanometrics (NANO) Issues Business Update, Reports FY23 Results
Create E-mail Alert Related Categories
Insiders' Blog, Momentum Movers, Trader TalkRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!